Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 27, 2026
Cadence Design Systems (CDNS) Q2 2026 Earnings: 24% Growth Expected After -13% Pullback

Cadence Design Systems (CDNS) Q2 2026 Earnings: 24% Growth Expected After -13% Pullback

Key Takeaways

  • Cadence Design Systems (CDNS) is scheduled to report Q2 2026 results today, July 27, after the market close, with a conference call to follow at 5:00 PM Eastern Time.
  • Wall Street consensus projects non-GAAP earnings per share (EPS) of $2.05 on revenue of approximately $1.58 billion, representing year-over-year revenue growth of roughly 24%.
  • The company's own Q2 guidance calls for non-GAAP EPS in the range of $2.02 to $2.08 and revenue between $1.555 billion and $1.595 billion.
  • Cadence enters the quarter with a record $8 billion backlog, driven by surging demand for its electronic design automation (EDA) software, intellectual property (IP), and hardware solutions tied to AI chip development.
  • The recently closed Hexagon Design & Engineering acquisition is expected to contribute roughly $160 million in 2026 revenue while creating near-term EPS dilution of approximately $0.28.
  • CDNS shares have pulled back roughly 13% over the past month, underperforming the broader vertical software sector, raising the stakes for today's report.

Why This Report Matters in the Current Environment

Cadence Design Systems sits at a critical juncture in the semiconductor supply chain. As a leading provider of EDA software, hardware emulation platforms, and silicon IP, its results give investors a direct window into R&D budgets across the chip sector. This Q2 2026 print carries extra weight because it is the first full quarter to reflect the Hexagon D&E acquisition, it lands during an intense AI-driven design cycle, and it follows a Q1 that featured both a raised full-year revenue outlook of $6.125–$6.225 billion and record backlog. I am watching closely to see whether organic momentum can offset acquisition-related margin pressure and whether demand from hyperscalers, memory makers, and analog firms stays strong.

What the Numbers Are Expected to Show

Analysts are looking for non-GAAP EPS of $2.05, up from $1.65 in Q2 2025 for about 24% earnings growth. Revenue is projected at roughly $1.58 billion, also implying 24% year-over-year expansion from the $1.275 billion posted last year. Cadence’s own guidance, issued with Q1 results, calls for revenue of $1.555–$1.595 billion and non-GAAP EPS of $2.02–$2.08, neatly bracketing the consensus and leaving room for a modest beat on solid execution.

The company has a solid history of topping expectations. In Q1 2026 it delivered non-GAAP EPS of $1.96 and revenue of $1.47 billion, beating estimates by $0.05 and $18 million. The prior four quarters also produced positive surprises. Key items to track in today’s release include growth across Core EDA, IP, and System Design & Analysis segments, non-GAAP operating margin (guided at 44.5%–45.5%), and any updates to full-year guidance. The IP business, which grew 22% in Q1 and is on its third straight year of 20%-plus expansion, remains especially noteworthy. I also checked this using Tickeron’s AI Screener to see how CDNS stacks up against other vertical software names.

Market Reaction and Current Sentiment

Investor sentiment ahead of the report feels measured. Even after a strong Q1 that included the raised outlook, shares fell about 3.3% the next day. Over the past month CDNS has declined roughly 13%, lagging the vertical software sector’s average gain of about 3.9%. Trading near $328–$330, the stock sits well below its 52-week high of $416.69 and below average analyst price targets of roughly $387–$396. This gap between operational strength and share-price performance suggests the market may be discounting near-term margin effects from the Hexagon deal, potential China export restrictions, and the stock’s still-elevated valuation. A clean beat-and-raise could help narrow that gap, while any hint of slowing organic growth or margin compression would likely intensify selling pressure. From what I see, the setup makes today’s print particularly important.

Forward Outlook and Items Worth Monitoring

Looking past the headline figures, several themes will shape interpretation of the results. First is the path of full-year guidance. Cadence entered 2026 targeting about 17% revenue growth at the midpoint and aims for the Rule of 60—revenue growth rate plus non-GAAP operating margin reaching or exceeding 60%. Any upward revision would strengthen the constructive case.

Second is the pace of AI monetization. Management has rolled out an agentic AI platform called AgentStack along with AI super agents (ChipStack, ViraStack, InnoStack) developed with Google Gemini and Nvidia. Early customer feedback has been positive, yet material revenue from these offerings is not yet in formal guidance. Comments on adoption and potential consumption-based pricing will be closely watched.

Third is the Hexagon D&E acquisition. With roughly $160 million in expected 2026 revenue and an estimated $0.28 near-term EPS dilution, investors will listen for updates on integration timing and the trajectory toward accretion in 2027. Finally, China exposure—about 13% of Q1 revenue—remains a variable given evolving export controls, though management has described design activity there as resilient.

How I Use Tickeron’s AI Tools

I regularly turn to Tickeron’s AI Screener when preparing for earnings season. The tool lets me quickly filter the market by industry, technical patterns, fundamentals, and AI-driven signals, helping me compare CDNS with peers and spot broader sector trends without spending hours on manual screens. It has become a standard part of my workflow for putting individual company results into context.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CDNS

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


CDNS in upward trend: 10-day moving average moved above 50-day moving average on October 02, 2026

The 10-day moving average for CDNS crossed bullishly above the 50-day moving average on October 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 21, 2026. You may want to consider a long position or call options on CDNS as a result. In 65 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.

The Moving Average Convergence Divergence (MACD) for CDNS just turned positive on September 21, 2026. Looking at past instances where CDNS's MACD turned positive, the stock continued to rise in 35 of 51 cases over the following month. The odds of a continued upward trend are 69%.

CDNS moved above its 50-day moving average on September 24, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +0.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where CDNS advanced for three days, in 222 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for CDNS moved below the 200-day moving average on September 18, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CDNS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.

CDNS broke above its upper Bollinger Band on September 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CDNS entered a downward trend on September 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 37 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. CDNS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 43 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.123) is normal, around the industry mean (51.456). P/E Ratio (64.950) is within average values for comparable stocks, (82.636). Projected Growth (PEG Ratio) (2.496) is also within normal values, averaging (3.135). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (13.141) is also within normal values, averaging (69.875).

Notable companies

The most notable companies in this group are Salesforce (NYSE:CRM), Shopify Inc (NASDAQ:SHOP), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Datadog (NASDAQ:DDOG), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM), Autodesk (NASDAQ:ADSK).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 9.9B. The market cap for tickers in the group ranges from 39 to 244.09B. SAPGF holds the highest valuation in this group at 244.09B. The lowest valued company is STIXF at 39.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 1%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 9%. RPGL experienced the highest price growth at 180%, while WCT experienced the biggest fall at -87%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was -45%. For the same stocks of the Industry, the average monthly volume growth was 20% and the average quarterly volume growth was -37%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 76
Price Growth Rating: 59
SMR Rating: 77
Profit Risk Rating: 94
Seasonality Score: 6 (-100 ... +100)
View a ticker or compare two or three
CDNS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of integrated circuits and electronic devices and provides software services

Industry PackagedSoftware

Industry
Electronic Production Equipment
Address
2655 Seely Avenue
Phone
+1 408 943-1234
Employees
13800
Web
https://www.cadence.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.